Full history for every metric is available with a Kvantra account
Hamilton Thorne Ltd. (HTL.TO)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 28 | 35 | 40 | 52 | 58 | 67 | 76 |
| Operating profit | $m | 0 | 0 | |||||
| Net profit | $m | 3 | 1 | 1 | 2 | 2 | -1 | -2 |
| EPS reported | $ | -0.00 | -0.02 | |||||
| Operating cashflow per share | $ | 0.03 | 0.03 | |||||
| Capex per share | $ | 0.03 | 0.03 | |||||
| FCF per share | $ | 0.00 | 0.00 | |||||
| Free cash flow | $m | 0 | 2 | |||||
| Net debt | $m | 12 | 13 | |||||
| Book value equity | $m | 65 | 65 | |||||
| Book value per share | $ | 0.44 | 0.42 | |||||
| Number of shares | m | 147.42 | 153.95 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 2.29 | 3.71 | |||||
| P/S LTM | x | 2.20 | 3.18 | |||||
| P/FCF LTM | x | 567.31 | 143.77 | |||||
| EV/EBITDA LTM | x | 30.07 | 36.05 | |||||
| EV/Sales LTM | x | 2.47 | 3.34 | |||||
| Earnings Yield LTM | % | -0.41% | -0.26% | |||||
| FCF Yield | % | 0.18% | 0.70% | |||||
| Quality | ||||||||
| ROE | % | -0.94% | -1.00% | |||||
| ROIC | % | 0.15% | 0.15% | |||||
| Operating margin | % | 0.41% | 0.41% | |||||
| Gross margin | % | 50.35% | 50.35% | |||||
| FCF/Sales | % | 0.39% | 0.39% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +15.55% | +16.27% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | +2076.4% | |||||
| Operating Profit Growth | % | -87.87% | -91.78% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.01 | 0.07 | |||||
| Net Debt/EBITDA | x | 3.30 | 3.30 | |||||
| EBIT/Net interest | x | 0.20 | 0.20 | |||||
| Net debt/market cap | % | 8.02% | 5.24% | |||||
| Net debt/Equity | x | 0.18 | 0.19 | |||||
| Gross debt/equity | x | 0.43 | 0.39 | |||||
Company overview
Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Hamilton Thorne Ltd. (HTL.TO)
Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free